*Last week, Argentine ADRs remained flat on average* Link to report: https://tinyurl.com/AdcapEqWk3Feb25 The Argentine stocks that posted the strongest weekly figures were Edenor (EDN), Central Puerto (CEPU) and Globant (GLOB) with increases of 8.0%, 5.5% and 4.5%, respectively. On the contrary, the companies with the weakest weekly performance were IRSA (IRS), Vista Energy (VIST) and Banco Macro (BMA) with decreases of 6.1%, 5.3% and 4.7%, respectively. The strongest sector was Utilities with an average increase of 4.2%, while the weakest sector was Oil and Gas with a 1.4% decline. Argentine ADRs are now 12% below their five-year highs from mid-January 2025. In January, the best-performing Argentine ADRs were BBVA Argentina (BBAR), Mercado Libre (MELI) and Bioceres (BIOX) with increases of 14.6%, 13.0% and 12.7%, respectively. On the flip side, the least performing stocks were Edenor (EDN), YPF and Transportadora de Gas del Sur (TGS) decreasing 8.9%, 7.2% and 3.5%, respectively. Year-to-date, BBVA Argentina (BBAR), Mercado Libre (MELI) and Bioceres (BIOX) continue leading the performance with gains of 14.6%, 13.0% and 12.7%, respectively. In contrast, Edenor (EDN), YPF and Transportadora de Gas del Sur (TGS) lagged behind declining 8.9%, 7.2% and 3.5%, respectively. The mean performance of listed ADRs shows a monthly increase of roughly 1.3%. In comparison, the DJI and the S&P 500 increased by 2.6% and 1.0%, while the Nasdaq100 decreased by 0.4%. Blue-Chip FX (CCL) rate closed at 1,186 AR$/US$. For the week, the top gainers (in dollars) were: *On the leader panel + others:* EDN (+10% in USD), CEPU (+8%) and PAM (+7%). *From the general panel:* INTR (+9%), ROSE (+9%) and DOME (+8%). *Among CEDEARs:* BBAS3 (+24%), PRIO3 (+21%) and IBM (+17%). *Indices* : DJI (+0.3%), SPX (-1.0%), and CCMP (-1.6%). Meanwhile, Merval (-0.1%) and EWZ (+5.8%). More on this report: Weekly flows, equity volumes, valuation multiples table for Argentina's Leader Panel and General Panel companies, and a banking sector's comparison table with 3Q24 results. To continue reading, please find this report attached. If you have any questions, please let us know.